Lack of adverse clopidogrel-atorvastatin clinical interaction.
Jacqueline
J
Saw
Eric J
EJ
Topol
D000069059:Atorvastatin; D000077144:Clopidogrel; D003327:Coronary Disease / Q000188:drug therapy*; D004347:Drug Interactions; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011758:Pyrroles / Q000009:adverse effects*; D012107:Research Design; D013988:Ticlopidine / Q000009:adverse effects* / Q000031:analogs & derivatives*
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D000077144:Clopidogrel; D013988:Ticlopidine